Tianda Pharmaceuticals Limited
HKEX:0455.HK
0.188 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 532.089 | 546.693 | 509.955 | 474.332 | 491.475 | 527.003 | 361.555 | 195.539 | 192.785 | 139.367 | 247.173 | 180.214 | 97.277 | 206.346 | 82.951 | 56.936 | 36.304 | 19.97 | 15.208 | 10.113 | 5.766 | 3.424 | 10.498 | 13.417 |
| Cost of Revenue
| 276.557 | 295.173 | 268.732 | 215.345 | 130.461 | 102.923 | 91.195 | 75.524 | 82.056 | 69.596 | 88.692 | 56.181 | 24.806 | 85.906 | 19.569 | 16.34 | 10.069 | 8.38 | 5.564 | 3.524 | 1.82 | 0 | 0 | 0 |
| Gross Profit
| 255.532 | 251.521 | 241.223 | 258.988 | 361.014 | 424.08 | 270.36 | 120.015 | 110.729 | 69.77 | 158.481 | 124.033 | 72.471 | 120.44 | 63.382 | 40.596 | 26.234 | 11.59 | 9.644 | 6.589 | 3.946 | 3.424 | 10.498 | 13.417 |
| Gross Profit Ratio
| 0.48 | 0.46 | 0.473 | 0.546 | 0.735 | 0.805 | 0.748 | 0.614 | 0.574 | 0.501 | 0.641 | 0.688 | 0.745 | 0.584 | 0.764 | 0.713 | 0.723 | 0.58 | 0.634 | 0.652 | 0.684 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 13.105 | 36.149 | 15.859 | 11.826 | 1.504 | 6.916 | 3.139 | 3.025 | 1.213 | 1.758 | 1.627 | 2.49 | 1.539 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 84.992 | 84.704 | 71.458 | 69.792 | 67.807 | 63.258 | 55.063 | 50.178 | 50.104 | 59.379 | 53.012 | 39.969 | 19.401 | 30.327 | 19.614 | 21.715 | 15.011 | 13.708 | 11.433 | 8.786 | 9.218 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 186.458 | 200.812 | 198.003 | 211.733 | 282.232 | 344.673 | 197.185 | 49.358 | 51.085 | 43.676 | 46.094 | 28.258 | 1.36 | 8.421 | 0.713 | 1.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 271.45 | 285.515 | 269.461 | 281.524 | 350.039 | 407.931 | 252.247 | 99.536 | 101.189 | 103.055 | 99.106 | 68.227 | 20.761 | 38.748 | 20.327 | 22.945 | 15.011 | 13.708 | 11.433 | 8.786 | 9.218 | 0 | 0 | 0 |
| Other Expenses
| 0.299 | 0 | -2.07 | -3.154 | -0.357 | 0.729 | -1.805 | 1.222 | -0.94 | -3.587 | -5.519 | -1.004 | -1.176 | -3.832 | 3.8 | -2.952 | -13.302 | 23.135 | 0.372 | -0.376 | 1.057 | 14.291 | 11.535 | 12.945 |
| Operating Expenses
| 284.555 | 321.665 | 283.25 | 290.196 | 351.186 | 411.44 | 253.582 | 100.649 | 101.462 | 101.226 | 95.214 | 69.713 | 19.585 | 34.916 | 16.904 | 19.993 | 1.709 | 36.842 | 11.805 | 8.409 | 10.275 | 14.291 | 11.535 | 12.945 |
| Operating Income
| -29.023 | -70.144 | -38.975 | -26.764 | 16.374 | 12.639 | 16.778 | 24.739 | 15.509 | -21.754 | 69.162 | 60.174 | 58.816 | 85.524 | 46.478 | 20.604 | 24.525 | -25.252 | -2.161 | -0.396 | -4.91 | -4.946 | 2.127 | 6.874 |
| Operating Income Ratio
| -0.055 | -0.128 | -0.076 | -0.056 | 0.033 | 0.024 | 0.046 | 0.127 | 0.08 | -0.156 | 0.28 | 0.334 | 0.605 | 0.414 | 0.56 | 0.362 | 0.676 | -1.264 | -0.142 | -0.039 | -0.852 | -1.445 | 0.203 | 0.512 |
| Total Other Income Expenses Net
| 3.329 | 6.291 | 10.957 | -0.677 | -0.446 | 13.528 | 13.164 | 13.383 | 9.158 | 7.194 | 1.16 | 8.537 | 5.93 | 34.63 | 4.458 | -1.276 | -134.611 | -11.759 | 8.697 | 1.98 | 0.858 | 6.358 | 6.966 | 7.996 |
| Income Before Tax
| -25.694 | -63.853 | -28.018 | -27.442 | 15.928 | 26.167 | 29.942 | 32.75 | 18.425 | -24.262 | 64.427 | 62.857 | 58.816 | 120.155 | 50.936 | 19.328 | -110.085 | -37.011 | 6.536 | 0.159 | -5.471 | -4.509 | 5.928 | 8.468 |
| Income Before Tax Ratio
| -0.048 | -0.117 | -0.055 | -0.058 | 0.032 | 0.05 | 0.083 | 0.167 | 0.096 | -0.174 | 0.261 | 0.349 | 0.605 | 0.582 | 0.614 | 0.339 | -3.032 | -1.853 | 0.43 | 0.016 | -0.949 | -1.317 | 0.565 | 0.631 |
| Income Tax Expense
| -0.689 | -4.863 | -6.343 | -1.524 | 7.128 | 10.184 | 7.78 | 7.997 | 5.058 | -1.245 | 15.477 | 12.098 | 14.847 | 18.718 | 10.244 | 5.638 | 2.831 | 0.056 | 0.052 | 0.292 | 0.191 | 0.017 | 1.072 | 0.203 |
| Net Income
| -24.155 | -54.636 | -21.675 | -25.918 | 8.8 | 2.657 | 10.008 | 12.442 | 6.569 | -17.942 | 22.05 | 37.74 | 43.096 | 67.426 | 21.287 | 2.752 | -112.917 | -37.067 | 6.483 | -0.654 | -5.739 | -4.527 | 4.857 | 8.265 |
| Net Income Ratio
| -0.045 | -0.1 | -0.043 | -0.055 | 0.018 | 0.005 | 0.028 | 0.064 | 0.034 | -0.129 | 0.089 | 0.209 | 0.443 | 0.327 | 0.257 | 0.048 | -3.11 | -1.856 | 0.426 | -0.065 | -0.995 | -1.322 | 0.463 | 0.616 |
| EPS
| -0.011 | -0.025 | -0.01 | -0.012 | 0.004 | 0.001 | 0.005 | 0.006 | 0.003 | -0.01 | 0.012 | 0.02 | 0.023 | 0.043 | 0.023 | 0.003 | -0.12 | -0.073 | 0.009 | -0.001 | -0.012 | -0.01 | 0.011 | 0.018 |
| EPS Diluted
| -0.011 | -0.025 | -0.01 | -0.012 | 0.004 | 0.001 | 0.005 | 0.006 | 0.003 | -0.01 | 0.012 | 0.02 | 0.023 | 0.043 | 0.023 | 0.003 | -0.12 | -0.073 | 0.009 | -0.001 | -0.012 | -0.01 | 0.011 | 0.018 |
| EBITDA
| 7.384 | -19.895 | -16.825 | -6.146 | 35.894 | 33.613 | 30.712 | 35.511 | 39.96 | -2.411 | 85.343 | 73.918 | 76.58 | 96.469 | 49.821 | 26.48 | 27.765 | -22.31 | 0.048 | 0.363 | -5.084 | -10.559 | -0.374 | 1.156 |
| EBITDA Ratio
| 0.014 | -0.036 | -0.033 | -0.013 | 0.073 | 0.064 | 0.085 | 0.182 | 0.207 | -0.017 | 0.345 | 0.41 | 0.787 | 0.468 | 0.601 | 0.465 | 0.765 | -1.117 | 0.003 | 0.036 | -0.882 | -3.084 | -0.036 | 0.086 |